Martin Klein

Martin Klein

Auto-generated profile, based on publicly available information

Martin Klein

Institute of Rheumatology, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Autoimmunity Reviews
Verified
Journal Article
Closed access
LMLucile Musset
Lucile Musset
YAYves Allenbach
Yves Allenbach
OBOlivier Benveniste
Olivier Benveniste
OBOlivier Boyer
Olivier Boyer
XBXavier Bossuyt
Xavier Bossuyt
MMMichael Mahler
Michael Mahler

15 September 2015 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JHJana Hurnakova
Jana Hurnakova
JZJakub Zavada
Jakub Zavada
PHPetra Hanova
Petra Hanova
HHHana Hulejova
Hana Hulejova
MKMartin Klein
Martin Klein
LŠLadislav Šenolt
Ladislav Šenolt
Calprotectin, a heterodimeric complex of S100A8/9 (MRP8/14), has been proposed as an important serum biomarker that reflects disease activity and structural joint damage in rheumatoid arthritis (RA). The objective of this cross-sectional study was to test the hypothesis that calprotectin is associated with clinical and ultrasound-determined disease activity in patients with RA. A total of 37 patients with RA (including 24 females, a mean disease duration of 20 months) underwent a clinical examination and 7-joint ultrasound score (German US-7) of the clinically dominant hand and foot to assess synovitis by grey-scale (GS) and synovial vascularity by power Doppler (PD) ultrasound using semiquantitative 0–3 grading. The levels of serum calprotectin and C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were determined at the time of the ultrasound assessment. We analysed the relationship between serum calprotectin level, traditional inflammatory markers, and ultrasound-determined synovitis. The levels of serum calprotectin were significantly correlated with swollen joint count (r = 0.465, p < 0.005), DAS28-ESR (r = 0.430, p < 0.01), ESR (r = 0.370, p < 0.05) and, in particular, CRP (r = 0.629, p < 0.001). Calprotectin was significantly associated with GS (r = 0.359, p < 0.05) and PD synovitis scores (r = 0.497, p < 0.005). Using multivariate regression analysis, calprotectin, adjusted for age and sex, was a better predictor of PD synovitis score (R2 = 0.765, p < 0.001) than CRP (R2 = 0.496, p < 0.001). The serum levels of calprotectin are significantly associated with clinical, laboratory and ultrasound assessments of RA disease activity. These results suggest that calprotectin might be superior to CRP for monitoring ultrasound-determined synovial inflammation in RA patients.

24 June 2015 in Rheumatology
Verified
Journal Article
Open access
PDF file
MKMartin Klein
Martin Klein
HMHeřman Mann
Heřman Mann
LPLenka Pleštilová
Lenka Pleštilová
JZJosef Zámečník
Josef Zámečník
ZBZoe Betteridge
Zoe Betteridge
JVJiří Vencovský
Jiří Vencovský
Objectives. Immune-mediated necrotizing myopathy (IMNM) is characterized by the predominant presence of necrotic muscle fibres in muscle biopsy and variable response to immunosuppressive treatment. The aims of this study were to analyse the temporal trend of IMNM incidence in our centre over the past 10 years and to explore the role of statins as possible causative agents. Methods. A retrospective evaluation of muscle biopsy results, clinical and laboratory data, including antibody associations of all patients with idiopathic inflammatory myopathy newly diagnosed between 2004 and June 2014, was performed. Available sera were tested for the presence of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (anti-HMGCR) autoantibodies. Results. Of 357 biopsied patients, 233 fulfilled criteria for inflammatory/immune-mediated myopathy, including 27 (11.6%) classified as IMNM. There were no patients with IMNM diagnosed between 2004 and 2007; subsequently, two to three cases of IMNM per year were seen during the period 2008–11, with a substantial increase to 18 cases (66.6% of all IMNM biopsies) in 2012–14. Thirteen of 27 patients (48%) had a history of statin use, 11 (85%) of whom had positive anti-HMGCR antibodies. There was no IMNM patient without a history of statin use who was anti-HMGCR antibody positive. Conclusion. Our data show an increasing incidence of IMNM, which is mainly accounted for by anti-HMGCR-positive IMNM associated with the use of statins.

1 August 2013 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
OSOlga Sánchez-Pernaute
Olga Sánchez-Pernaute
MFMaria Filkova
Maria Filkova
AGAntonio Gabucio
Antonio Gabucio
MKMartin Klein
Martin Klein
HMHanna Maciejewska-Rodrigues
Hanna Maciejewska-Rodrigues
AJAstrid Juengel
Astrid Juengel
Objective Fibrin deposits are characteristic of the synovial tissues in rheumatoid arthritis (RA). Once citrullinated, fibrin becomes an autoantigen and is thought to contribute in this way to perpetuate the disease. Our study aimed to analyse the responses of RA synovial fibroblasts (RASF) to native and citrullinated fibrin. Methods The transcriptome induced by fibrin in RASF was approached with whole-genome-based gene expression arrays. The upregulation of selected pro-inflammatory genes by fibrin was confirmed in additional primary cell cultures using quantitative PCR and ELISA. Citrullination reactions were carried out with recombinant human peptidylarginine deiminases (PAD) 2 and 4. Results In the whole-genome array native fibrin was found to modulate the gene expression profile of RASF, particularly upregulating mRNA levels of several pro-inflammatory cytokines. The induction of interleukin (IL)-6 and IL-8 by fibrin was confirmed in additional samples at both the mRNA and the protein level. Blocking and knockdown experiments showed the participation of toll-like receptor (TLR)4 in the induction of both cytokines. As compared with the native macromolecule, PAD2-citrullinated fibrin induced significantly higher expression of the pro-inflammatory cytokines in these cells. Conclusions Our results suggest that fibrin mediates inflammatory responses in RASF via a TLR4 pathway. In this way, fibrin and particularly its citrullinated form may contribute to sustain the cytokine burst in RA.

23 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JHJana Hurnakova
Jana Hurnakova
HHHana Hulejova
Hana Hulejova
JZJakub Zavada
Jakub Zavada
PHPetra Hanova
Petra Hanova
MKMartin Komarc
Martin Komarc
LŠLadislav Šenolt
Ladislav Šenolt
Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) disease activity. In the current study, we investigated whether calprotectin is a better biomarker than CRP for predicting clinical activity and ultrasound parameters in patients with RA. A total of 160 patients with RA underwent clinical (swollen joint count—SJC, tender joint count—TJC, Disease Activity Score—DAS28, Clinical Disease Activity Index—CDAI, and simplified Disease Activity Index—SDAI) and ultrasound (German US7) examination. Clinical and laboratory measures were correlated with ultrasound findings using Spearman´s correlation coefficient. Differences in serum calprotectin levels in patients with variable disease activity according to the DAS28-ESR and CDAI scores were assessed using ANOVA. Multivariate regression analysis was used to determine the predictive values of calprotectin, CRP and SJC for CDAI and PD US synovitis scores. Serum calprotectin was significantly associated with DAS28-ESR (r = 0.321, p<0.001), DAS28-CRP (r = 0.346, p<0.001), SDAI (r = 0.305, p<0.001), CDAI (r = 0.279, p<0.001) scores and CRP levels (r = 0.556, p<0.001). Moreover, calprotectin was significantly correlated with GS (r = 0.379, p<0.001) and PD synovitis scores (r = 0.419, p<0.001). The multivariate regression analysis showed that calprotectin is a better predictor of the CDAI score and PD US synovitis than CRP. The results of this study support an additional role of calprotectin in assessing inflammatory activity in patients with RA.

13 July 2016 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
PDF file
LELouise Ekholm
Louise Ekholm
SVSaskia Vosslamber
Saskia Vosslamber
ATAnna Tjärnlund
Anna Tjärnlund
TJTamarah de Jong
Tamarah de Jong
ZBZoe Betteridge
Zoe Betteridge
CVCor L. Verweij
Cor L. Verweij